Many Investors Still Treating Gilead: 4 Launches This Year Could Prove Them Wrong
Gilead sits at a crossroads: the HIV backbone remains strong, but a quartet of new launches could reshape the company...
Get guidance on choosing ETFs over mutual funds for Sp 500 retirement investing. We cover cost, liquidity, and tax considerations to help decide.
25,646 articlesGilead sits at a crossroads: the HIV backbone remains strong, but a quartet of new launches could reshape the company...
Binance releases its June proof of reserves, revealing higher Bitcoin balances against a backdrop of weaker stablecoi...
A viral moment linked to Suze Orman has reignited a national discussion about who bears the burden when a relative di...
Berkshire Hathaway's July 2026 moves reveal a rotating bet toward cash-generating, earnings-ready names. Delta Air Li...
Microsoft CEO Satya Nadella charts a pragmatic path for enterprise AI: keep data within your own boundary, govern wit...
This analysis breaks down what investors should watch in first horizon (fhn) 2026 earnings, with clear guidance on me...
SoFi’s stock faced a sharp pullback in January. This article breaks down the factors behind the move, what it signals...
IP Strategy said its board approved a buyback of up to 1,000,000 common shares through Dec. 31, 2026, potentially tri...
When sentiment hits extreme fear, smart investors pause and plan. This guide explains what the crypto market flashing...
Workday posted a solid Q4 beat on earnings and revenue, yet forward guidance disappointed investors. Shares tumbled a...
NVIDIA beat estimates with $68.1 billion in Q4 revenue and strong Q1 guidance, led by data-center demand. Analysts we...
As blockchains shed some public-by-default assumptions, ethereum both pivoting privacy raises questions for investors...